You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – With $36 million in new funding, clinical testing firm Genalyte is continuing efforts to develop its Maverick Detection System for rapid blood testing in outpatient settings like doctors' offices.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.